Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2002
10/03/2002WO2002076950A2 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
10/03/2002WO2002076949A1 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
10/03/2002WO2002076947A1 Mch antagonists and their use in the treatment of obesity
10/03/2002WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002WO2002076458A1 Antimicrobial drug reduced in effect on heart
10/03/2002WO2002076457A1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
10/03/2002WO2002076447A1 Hallogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of il-1 and tnf
10/03/2002WO2002076438A2 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
10/03/2002WO2002076404A2 Fatty alcohol drug conjugates
10/03/2002WO2002076177A2 Design and synthesis of optimized ligands for ppar
10/03/2002WO2002062784A8 Piperidinee derivatives as neurokinin 1 antagonists
10/03/2002WO2002026731A3 Quaternary amidino based inhibitors of factor xa
10/03/2002WO2001085095A3 Chiral fluoroquinolizinone arginine salt forms
10/03/2002WO2001019800A9 Mediators of hedgehog signaling pathways, compositions and uses related thereto
10/03/2002WO2000034265A3 Quinoline-indole antimicrobial agents
10/03/2002US20020143191 Novel stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas
10/03/2002US20020143046 Used as calcium channel blockers
10/03/2002US20020143044 Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
10/03/2002US20020143032 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/03/2002US20020143026 Induce mitotic arrest thereby making them useful as anti-cancer agents; also for therapy of diseases which can be treated by inducing mitotic arrest
10/03/2002US20020143024 As antihypertensive agents; for therapy of disorders related to renal, glomerular and mesangial cell function; therapy of endotoxemia or endotoxin shock as well as hemorrhagic shock; useful in alleviation of pain associated cancer
10/03/2002US20020143023 Dihydropyrimidine compounds and compositions containing the same
10/03/2002US20020143020 Novel piperazine derivatives
10/03/2002US20020143017 Pyridazinone aldose reductase inhibitors
10/03/2002US20020143014 Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereof
10/03/2002US20020143011 Tri-substituted phenyl derivatives and processes for their preparation
10/03/2002US20020143007 Donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase; for use in therapy
10/03/2002US20020142969 Using didepsipeptide for the control of endoparasites in medicine and veterinary medicine
10/03/2002US20020142967 Thrombin inhibitors
10/03/2002US20020142023 Insecticide, miticide
10/03/2002CA2442364A1 Process for the preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof
10/03/2002CA2442012A1 Chemical derivatives and their use as anti-telomerase agent
10/03/2002CA2441933A1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
10/03/2002CA2441790A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/02/2002WO2001077084A1 Substituted phenyluracils
10/02/2002EP1245567A1 HIV inhibiting pyrimidine derivatives
10/02/2002EP1245229A2 Methods and compositions for inhibition of angiogenesis
10/02/2002EP1244650A1 Arylamine derivatives and their use as anti-telomerase agent
10/02/2002EP1244648A1 Chemokine receptor binding heterocyclic compounds
10/02/2002EP1244647A1 Quinazoline derivatives as vegf inhibitors
10/02/2002EP1244642A1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators
10/02/2002EP1244637A1 Butyne diol derivatives
10/02/2002EP1244635A2 4-aryl-1-difluoromethoxyimidazole
10/02/2002EP1244631A1 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
10/02/2002EP1244628A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/02/2002EP1244627A1 Picolinic acid derivatives and their use as fungicides
10/02/2002EP1244620A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244452A1 Urotensin-ii receptor antagonists
10/02/2002EP1244451A1 Substituted piperazine and piperidine calcium channel blockers
10/02/2002EP1244446A1 Thrombopoietin mimetics
10/02/2002EP1098894B1 Fkbp inhibitors
10/02/2002EP1098648B1 Pharmaceutical compositions comprising hydroxylansoprazole and uses thereof
10/02/2002EP1047684B1 Substituted alpha,beta-anellated butyrolactones
10/02/2002EP0966285B1 Use of (+)mefloquine for the treatment of malaria
10/02/2002EP0963484B1 Sizing of paper
10/02/2002EP0906279B1 Pyrrole derivatives
10/02/2002EP0871465B1 Use of ritonavir (abt-538) for improving the pharmacokinetics of drugs metabolized by cytochrome p450 in a method of treating aids
10/02/2002EP0843675B1 Aza-anthracyclinone derivatives
10/02/2002EP0706521B1 Imides as tnf alpha inhibitors
10/02/2002EP0689534B1 Amide derivatives as 5-ht 1a? ligands
10/02/2002CN1372553A Novel thiazine or pyrazine derivatives
10/02/2002CN1372552A Pyrimidine derivatives and herbicides containing the same
10/02/2002CN1372549A Fungicidies
10/02/2002CN1372547A Aminoalkoxy carbazoles for the treatment of CNS diseases
10/02/2002CN1372546A Fused pyrrolecarboxamides GABA brain receptor ligands
10/02/2002CN1372541A Sulfonyl carboxamide derivatives, method for their production and their use as medicaments
10/02/2002CN1091768C Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
10/02/2002CN1091767C Nicotine extraction process
10/02/2002CN1091764C Pesticidal sulfur compounds
10/02/2002CN1091595C Use of a compound in preparing medicine for curing dyspepsia
10/02/2002CN1091594C Use of anti-viral compound in preparing medicine for curing virus infection
10/02/2002CA2404759A1 Substituted phenyluracils
10/01/2002US6458985 Use of compressed CO2 in chemical reactions
10/01/2002US6458951 For treatment of male erectile dysfunction, female sexual dysfunction
10/01/2002US6458950 Compounds and pharmaceutical compositions containing the same
10/01/2002US6458948 Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt
10/01/2002US6458844 Antiinflammatory agents
10/01/2002US6458823 4,5-diamino derivatives of (1h)- pyrazoles and their use in the treatment of disorders associated with smooth muscle contraction, which include, urinary incontinence, hypertension, asthama, premature labor, irritable bowl syndrom
10/01/2002US6458822 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/01/2002US6458813 2-cyclohexyloxy-5-(2-chlorophenylcarbonylamino)pyridine, for example; treating inflammation, pain, diabetes, cancer
10/01/2002US6458812 Muscarinic antagonists
10/01/2002US6458810 Pharmaceutically active isoindoline derivatives
10/01/2002US6458800 1,2-annelated quinoline derivatives
10/01/2002US6458793 Heterocyclic derivatives which inhibit factor Xa
10/01/2002US6458792 Medicament for the treatment of inflammatory, immunological, bronchopulmonary, cardiovascular, oncological or cns-degenerative disorders.
10/01/2002US6458790 Substituted piperidines as melanocortin receptor agonists
10/01/2002US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated
10/01/2002US6458784 Vitronectin receptor antagonists
10/01/2002US6458783 Non-imidazole benzodiazepine inhibitors of farnesyl protein transferase
10/01/2002US6458744 A 4-thiomethylpyrazole
10/01/2002CA2272719C Apo b-secretion/mtp inhibitory amides
10/01/2002CA2245857C 1,4-dihydropyridine compounds as bradykinin antagonists
10/01/2002CA2228370C Piperazino derivatives as neurokinin antagonists
10/01/2002CA2059708C Indole derivatives
09/2002
09/30/2002CA2379791A1 Novel triazine compounds useful as sorbitol dehydrogenase inhibitors
09/26/2002WO2002074767A1 Metalloproteinase inhibitors
09/26/2002WO2002074766A1 Method of preparing lansoprazole and its intermediate
09/26/2002WO2002074765A1 Phenyl derivatives 3
09/26/2002WO2002074764A2 Piperazine derivatives and their use as 5-ht1b ligands
1 ... 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 ... 1080